Journal
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES
Volume 13, Issue 3, Pages 521-534Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s12539-021-00447-2
Keywords
Peptide; Docking; In silico mutagenesis; Simulation; Free energy; PCA
Categories
Funding
- Key Research Area Grant of the Ministry of Science and Technology of China [2016YFA0501703]
- National Science Foundation of China [32070662, 61832019, 32030063]
- Science and Technology Commission of Shanghai Municipality [19430750600]
- SJTU JiRLMDS Joint Research Fund
- Joint Research Funds for Medical and Engineering and Scientific Research at Shanghai Jiao Tong University [YG2021ZD02]
Ask authors/readers for more resources
The research repurposed a small peptide from a previous study and designed more peptides using in silico mutagenesis to increase their binding affinity with the virus. The results showed that the designed peptides have the potential to hinder the progression of SARS-CoV-2.
The prolific spread of COVID-19 caused by a novel coronavirus (SARS-CoV-2) from its epicenter in Wuhan, China, to every nook and cranny of the world after December 2019, jeopardize the prevailing health system in the world and has raised serious concerns about human safety. Multi-directional efforts are made to design small molecule inhibitors, and vaccines and many other therapeutic options are practiced, but their final therapeutic potential is still to be tested. Using the old drug or vaccine or peptides could aid this process to avoid such long experimental procedures. Hence, here, we have repurposed a small peptide (ATLQAIAS) from the previous study, which reported the inhibitory effects of this peptide. We used in silico mutagenesis approach to design more peptides from the native wild peptide, which revealed that substitutions (T2W, T2Y, L3R, and A5W) could increase the binding affinity of the peptide towards the 3CLpro. Furthermore, using MD simulation and free energy calculation confirmed its dynamics stability and stronger binding affinities. Per-residue energy decomposition analysis revealed that the specified substitution significantly increased the binding affinity at the residue level. Our wide-ranging analyses of binding affinities disclosed that our designed peptide owns the potential to hinder the SARS-CoV-2 and will reduce the progression of SARS-CoV-2-borne pneumonia. Our research strongly suggests the experimental and clinical validation of these peptides to curtail the recent corona outbreak. Graphic abstract
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available